What is CVE-2018-14789?

CVE-2018-14789 is a medium-severity vulnerability in Philips Intellispace Cardiovascular, classified under Unquoted Search Path or Element. CVSS score: 6.7/10. Published 2018-08-22.

How severe is CVE-2018-14789?

Medium severity. CVSS v3 base score is 6.7 out of 10.

Vulnerability in Philips Intellispace Cardiovascular

CVE-2018-14789

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.

EPSS: 0.004 (36.5th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.7 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H.

Affected products

Philips Intellispace_cardiovascular
Philips Intellispace Cardiovascular (Iscv) Products — versions IntelliSpace Cardiovascular, Version 3.1 or prior, Xcelera Version 4.1 or prior
Philips Xcelera

Weakness classification (CWE)

CWE-428 — Unquoted Search Path or Element

References

ics-cert@hq.dhs.gov (x_refsource_CONFIRM, Vendor Advisory)
ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2018-14789?: CVE-2018-14789 is a medium-severity vulnerability in Philips Intellispace Cardiovascular, classified under Unquoted Search Path or Element. CVSS score: 6.7/10. Published 2018-08-22.
How severe is CVE-2018-14789?: Medium severity. CVSS v3 base score is 6.7 out of 10.